Lilly sales of new diabetes drug accelerate on rising patient demand

Lilly sales of new diabetes drug accelerate on rising patient demand

Source: 
BioPharma Dive
snippet: 

Eli Lilly’s new diabetes medicine Mounjaro outpaced Wall Street sales forecasts during the third quarter, fueled by strong patient demand and widening insurer coverage.